Properties (110)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:abstract |
A method for producing a recombinant protein.
|
| gptkbp:applicationNumber |
10/780,123
|
| gptkbp:applicationStatus |
published
|
| gptkbp:applicationType |
non-provisional
|
| gptkbp:assignee |
gptkb:ABC_Corporation
|
| gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
| gptkbp:claims |
20
|
| gptkbp:description |
This patent describes a novel method for gene editing.
|
| gptkbp:examiner |
Jane_Smith
|
| gptkbp:expirationDate |
2024-02-06
|
| gptkbp:fieldOfInvention |
biotechnology
|
| gptkbp:fieldOfUse |
pharmaceuticals
|
| gptkbp:filingDate |
2004-02-06
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,560 C11
|
| gptkbp:internationalClassification |
C12N_15/00
|
| gptkbp:inventor |
gptkb:John_Doe
|
| gptkbp:inventorCountry |
gptkb:USA
|
| gptkbp:issueDate |
2004-09-14
|
| gptkbp:issuedBy |
gptkb:United_States_Patent_and_Trademark_Office
|
| gptkbp:legalStatus |
granted
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:patentAbstract |
used in educational settings.
peer-reviewed. meets industry standards. available for licensing. developed over several years. commercially viable. can be enforced in court. developed in collaboration with universities. funded by government grants. part of the innovation ecosystem. can be assigned to another entity. represents a significant innovation. creates research opportunities. faces innovation challenges. fosters industry partnerships. receives innovation funding. achieved commercial success. significant impact on biotechnology. creates ethical strategies. creates innovation strategies. develops commercialization strategies. develops global impact strategies. develops innovation ecosystem strategies. develops societal strategies. faces commercialization challenges. faces global impact challenges. formulates regulatory strategies. has societal implications. involves partnerships with industry. provides global opportunities. |
| gptkbp:patentCitation |
gptkb:US_5,123,456_A
exclusive facilitates technology transfer. faced challenges during the application process. reflects global trends. influences patent policy. raises ethical considerations. used in academic research. aligns with future trends. guides future research. promotes research collaboration. aligns with market trends. expected to influence future research. part of a larger patent strategy. addresses societal challenges. attracts research funding. establishes research strategies. formulates market strategies. has a significant market potential. navigates innovation ecosystem challenges. raises ethical challenges. reflects trends in biotechnology. |
| gptkbp:patentClassification |
C12N
C12N_15 |
| gptkbp:patentExpiration |
2024-02-06
|
| gptkbp:patentFamily |
US_6,789,560_C11,_US_7,123,456_B2
|
| gptkbp:patentField |
molecular biology
|
| gptkbp:patentFilingDate |
published in scientific journals.
increases public awareness. |
| gptkbp:patentLink |
has a clear commercialization path.
https://patents.google.com/patent/US6789560C11 |
| gptkbp:patentLitigation |
can be subject to litigation.
|
| gptkbp:patentMaintenanceFee |
required every 4 years.
addresses sustainability challenges. addresses sustainability issues. considered valuable in the field. creates sustainability strategies. demonstrated utility in industry. |
| gptkbp:patentNumber |
6,789,560
|
| gptkbp:patentOwner |
gptkb:XYZ_Biotech_Inc.
|
| gptkbp:patentStatus |
maintenance fee paid.
covers a broad range of applications. |
| gptkbp:patentType |
national
utility Utility patent for a process. subject to regulations. presents future opportunities. offers licensing opportunities. has a global impact. faces regulatory challenges. approved after rigorous examination. implements global strategies. offers innovation opportunities. |
| gptkbp:priorityDate |
2003-02-06
|
| gptkbp:relatedPatent |
US_6,789,561_C11
|
| gptkbp:relatedTo |
gptkb:US_6,123,456_A1
|
| gptkbp:status |
active
|
| gptkbp:technology |
genetic engineering
|